mTOR, as key protein of the PI3K/AKT pathway, acts both upstream and downstream of AKT, and aberrant mTOR activation of promotes survival and proliferation of tumor cells in several human cancers (Saxton and Sabatini, 2017; Chamcheu et al., 2019). This evidence concerns the gene PIK3CA and neoplasm.